TVAX-028: Clinical Trials

1 trial of TVAX-028, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1

Follow TVAX-028: new trials by email Literature Review of TVAX-028 trials Research Report on TVAX-028

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of TVAX-028 in the Treatment of Chronic Hepatitis B
TVAX-028, Adjuvant - HBV Infection
Phase 1Not yet recruitingGrand Theravac Life Sciences (Nanjing) Co., Ltd.322026-05-312026-06-29

Sponsors

Grand Theravac Life Sciences (Nanjing) Co., Ltd. (1)